EOLS
EOLS
US30052C1071
Evolus, Inc. Common Stock
Loading chart...

Company Profile

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Latest News

Related stocks

AQST
AQST • United States
Aquestive Therapeutics, Inc.
4.78 USD
599.95M USD 1Y -23.2%
ESPR
ESPR • United States
Esperion Therapeutics, Inc.
3.18 USD
819.46M USD
COLL
COLL • United States
Collegium Pharmaceutical, Inc.
22.09 USD
719.15M USD 1Y -33.3%
AMPH
AMPH • United States
Amphastar Pharmaceuticals, Inc.
26.62 USD
1.13B USD 1Y -0.7%
GTII.CN
GTII.CN • United States
GreenThumb
9.58 CAD
1.47B USD 1Y -21.2%
ETON
ETON • United States
Eton Pharmaceuticals, Inc.
55.21 USD
1.58B USD 1Y +161.6%
TLRY
TLRY • Canada
Tilray Brands, Inc.
3.54 USD
523.15M USD 1Y -79.1%
IRWD
IRWD • United States
Ironwood Pharmaceuticals, Inc.
3.82 USD
631.22M USD 1Y +144.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
62.1% p.a.
Max Drawdown (5Y)
-77.5%
Sharpe Ratio (5Y)
0.00
Beta Factor
1.34
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (62.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -92.4% in the extended horizon.
ende